Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Side Effects of Erdafitinib and How to Manage ThemErdafitinib may cause some serious side effects. First are eye problems, including dry or inflamed eyes, inflammation of the corne···【more】
Article source：Captain MedicineRelease date：2026-04-03Recommended：24
Erdafitinib and Its IndicationsErdafitinib is a prescription medicine specifically used to treat adults with bladder cancer (urothelial cancer) whose cancer has spread or cannot be···【more】
Article source：Captain MedicineRelease date：2026-04-03Recommended：29
Preparations and Precautions Before Taking ErdafitinibBefore taking erdafitinib, be sure to inform your healthcare provider of all your health conditions. Special attention should ···【more】
Article source：Captain MedicineRelease date：2026-04-03Recommended：24
How to Take Erdafitinib CorrectlyAlthough the specific dosage must be determined by your doctor based on your individual circumstances (including blood phosphorus levels, body weig···【more】
Article source：Captain MedicineRelease date：2026-04-03Recommended：27
Is Belumosudil Effective?The efficacy of belumosudil has been validated in two clinical studies involving a total of 186 patients with chronic graft-versus-host disease (GVHD). In ···【more】
Article source：Captain MedicineRelease date：2026-04-02Recommended：31
Dosage and Missed Dose Administration of BelumosudilBelumosudil tablets should be swallowed whole with a full glass of water. Under no circumstances should they be split, crushed, ···【more】
Article source：Captain MedicineRelease date：2026-04-02Recommended：33
Unique Immune Modulating Mechanism of BelumosudilChronic GVHD is characterized by severe immune system imbalance. Following hematopoietic stem cell transplantation, donor immune ce···【more】
Article source：Captain MedicineRelease date：2026-04-02Recommended：34
Common Side Effects of BelumosudilIn clinical studies, some common side effects were reported in patients taking belumosudil. These included infections, fatigue or weakness, nausea···【more】
Article source：Captain MedicineRelease date：2026-04-02Recommended：28
While effectively inhibiting tumor growth, erlotinib may also cause a range of side effects. These adverse reactions vary from person to person. Most patients may experience mild t···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：34
Erlotinib is a targeted therapeutic agent directed against specific gene mutations, primarily indicated for the treatment of non-small cell lung cancer and advanced pancreatic canc···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：34
Ponatinib is a potent tyrosine kinase inhibitor indicated primarily for the treatment of chronic myeloid leukemia (CML) and certain types of acute lymphoblastic leukemia (ALL), esp···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：33
Ponatinib is a prescription medication. Patients must not adjust their dosage or discontinue treatment on their own. All dosage modifications should be made under close supervision···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：39
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：2242025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4512024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：2302025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：2432025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：2232025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：2522025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：2322025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：2142025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
